Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

OBJECTIVES: Chronic hepatitis C virus (HCV) is a leading cause of hospitalization and death in populations coinfected with human immunodeficiency virus (HIV). Sofosbuvir (SOF) is a pan-genotypic drug that should be combined with other agents as an oral treatment for HCV. We performed a 5-year horizo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cenderello, Giovanni, Artioli, Stefania, Viscoli, Claudio, Pasa, Ambra, Giacomini, Mauro, Giannini, Barbara, Dentone, Chiara, Nicolini, Laura Ambra, Cassola, Giovanni, Di Biagio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706121/
https://www.ncbi.nlm.nih.gov/pubmed/26770065
http://dx.doi.org/10.2147/CEOR.S93641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706121/
https://www.ncbi.nlm.nih.gov/pubmed/26770065
http://dx.doi.org/10.2147/CEOR.S93641

Ejemplares similares